Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection
Tokyo, Oct 2, 2006 (JCN) - Sankyo Co., Ltd., a wholly owned subsidiary of Daiichi Sankyo Company, Limited, has filed an application for an additional indication for Fentanyl Injection 0.1 mg and 0.25 mg (generic name: fentanyl citrate) with the Ministry of Health, Labour and Welfare.